martes, 18 de agosto de 2026

Glofitamab-GemOx Shows Sustained Survival Benefit in DLBCL Edited by Gargi Mukherjee

https://www.medscape.com/viewarticle/glofitamab-gemox-shows-sustained-survival-benefit-dlbcl-2026a1000sle?src=

No hay comentarios:

Publicar un comentario